Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review
Susanna Meade, Jeremy Liu Chen Kiow, Cristian Aldo Massaro, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 13

Showing 13 citing articles:

Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Manoj Kumar, Selvasankar Murugesan, N Ibrahim, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence
Anna Lucia Cannarozzi, Anna Latiano, Luca Massimino, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 5
A decade of advances in human gut microbiome-derived biotherapeutics
Alena L. Pribyl, Philip Hugenholtz, Matthew A. Cooper
Nature Microbiology (2025)
Closed Access
Multi-omics perspective: mechanisms of gastrointestinal injury repair
Zhao Hai-bin, Zhigang Zhang, Hongyu Liu, et al.
Burns & Trauma (2025) Vol. 13
Open Access
Lifelong partners: Gut microbiota-immune cell interactions from infancy to old age
Julia A. Brown, Hilal Bashir, Melody Yue Zeng
Mucosal Immunology (2025)
Open Access
Specific Composition Diets and Improvement of Symptoms of Immune-Mediated Inflammatory Diseases in Adulthood—Could the Comparison Between Diets Be Improved?
María Dolores Guerrero Aznar, M Dolores Villanueva Guerrero, Margarita Beltrán García, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 493-493
Open Access
Gut microbiome predictors of advanced therapy response in Crohn’s disease: protocol for the OPTIMIST prospective, longitudinal, observational pilot study in Canada
Cristian Aldo Massaro, Susanna Meade, Fanny Laure Lemarié, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e094280-e094280
Open Access
Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways
Meiling Liu, Siyi Guo, Liang Wang
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 3
S-Wipe: stool sample collection for metabolomic gut health tracking
Alexey V. Melnik, Konstantin Pobozhev, Ali Lotfi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Gut Microbiota Affects Anti‐TNF Responsiveness by Activating the NAD+ Salvage Pathway in Ulcerative Colitis
Lei Jing, Lin Lv, Li Zhong, et al.
Advanced Science (2024)
Open Access
Efficacy of diets with specific compositions to reduce the symptoms of immune-mediated diseases. Narrative review
Guerrero Aznar M Dolores, Villanueva Guerrero M Dolores, Hernández Cruz Blanca
PharmaNutrition (2024), pp. 100394-100394
Open Access
Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
Hiroshi Matsumoto, Momoyo Sasahira, Tei Tei Go, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2125-2125
Open Access
Disease signatures in the gut metagenome of a prospective family cohort of inflammatory bowel disease
Malte Rühlemann, Silvio Waschina, Eike Matthias Wacker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top